APA (7th ed.) Citation

C, B., M, D., F, M., S, C., D, K., R, S., . . . Y, C. (2024). Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology, 13(4), 660. https://doi.org/10.1002/psp4.13114

Chicago Style (17th ed.) Citation

C, Bowman, Dolton M, Ma F, Cheeti S, Kuruvilla D, Sane R, Kassir N, and Chen Y. "Understanding CYP3A4 and P-gp Mediated Drug-drug Interactions Through PBPK Modeling - Case Example of Pralsetinib." CPT: Pharmacometrics & Systems Pharmacology 13, no. 4 (2024): 660. https://doi.org/10.1002/psp4.13114.

MLA (9th ed.) Citation

C, Bowman, et al. "Understanding CYP3A4 and P-gp Mediated Drug-drug Interactions Through PBPK Modeling - Case Example of Pralsetinib." CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 4, 2024, p. 660, https://doi.org/10.1002/psp4.13114.